Lavoie L, van de Werve G
Department of Nutrition, Faculty of Medicine, University of Montreal, Quebec, Canada.
Metabolism. 1991 Oct;40(10):1031-6. doi: 10.1016/0026-0495(91)90125-g.
The contribution of hormone-stimulated glycogenolysis to hepatic glucose production was studied in hepatocytes from streptozotocin diabetic rats. To this end, the activation of glycogen phosphorylase by glucagon, vasopressin, and the alpha 1-adrenergic agonist phenylephrine was compared in hepatocytes from normal and diabetic rats and related to glycogen content, glucose production, and microsomal glucose-6-phosphatase activity. Streptozotocin-induced diabetes reduced the glycogen content and the amount of total (a + b) phosphorylase in hepatocytes proportionally to the severity of the disease. In cells from severely diabetic rats (group 1), the responsiveness of activation of phosphorylase to the hormones was reduced by about half, consistent with a 45% reduction in total phosphorylase. In addition, the sensitivity of phosphorylase activation to all hormones investigated was decreased by about 1 order of magnitude or more in cells of this group. In hepatocytes from rats with milder diabetes (group 2), maximal phosphorylase activation reached an intermediate value between that of the control group and of group 1. In response to all hormones investigated, group 2 diabetic rat hepatocytes produced less glucose than control rat liver cells, while in group 1 there was no increase in glucose production at all, presumably because glycogen concentration was too low. However, in group 2 diabetic rat hepatocytes, glucagon-stimulated glucose production, unlike phosphorylase activation, did not show decrease sensitivity, presumably because glucose-6-phosphatase activity is increased by diabetes. Our results thus indicate that hormone-stimulated liver glycogenolysis is unlikely to contribute to enhanced glucose production in insulin-deficient diabetes, despite increased glucose-6-phosphatase activity.
在链脲佐菌素诱导的糖尿病大鼠的肝细胞中,研究了激素刺激的糖原分解对肝脏葡萄糖生成的贡献。为此,比较了正常大鼠和糖尿病大鼠肝细胞中胰高血糖素、血管加压素和α1-肾上腺素能激动剂去氧肾上腺素对糖原磷酸化酶的激活作用,并将其与糖原含量、葡萄糖生成和微粒体葡萄糖-6-磷酸酶活性相关联。链脲佐菌素诱导的糖尿病按疾病严重程度成比例降低了肝细胞中的糖原含量和总(a + b)磷酸化酶的量。在重度糖尿病大鼠(第1组)的细胞中,磷酸化酶激活对激素的反应性降低了约一半,这与总磷酸化酶减少45%一致。此外,在该组细胞中,磷酸化酶激活对所有研究激素的敏感性降低了约1个数量级或更多。在患有轻度糖尿病的大鼠(第2组)的肝细胞中,最大磷酸化酶激活达到对照组和第1组之间的中间值。响应所有研究的激素,第2组糖尿病大鼠肝细胞产生的葡萄糖比对照大鼠肝细胞少,而在第1组中,葡萄糖生成根本没有增加,可能是因为糖原浓度过低。然而,在第2组糖尿病大鼠肝细胞中,与磷酸化酶激活不同,胰高血糖素刺激的葡萄糖生成并未显示出敏感性降低,可能是因为糖尿病会增加葡萄糖-6-磷酸酶的活性。因此,我们的结果表明,尽管葡萄糖-6-磷酸酶活性增加,但激素刺激的肝脏糖原分解不太可能导致胰岛素缺乏型糖尿病中葡萄糖生成增加。